Morepen Laboratories clears fourth USFDA inspection at Masulkhana facility with NIL 483

Clinical exclusivity for indigenous medicines can improve long-term affordability and access

Rusan Pharma secures PMDA GMP approval for Ankleshwar and Dehradun facilities